Announce Date | 05/12/2025 |
EPS Normalized Actual | $-0.82 (Beat by $0.04) |
EPS GAAP Actual | $-0.82 (Beat by $0.04) |
Revenue Actual | $0.001163B |
Revenue Surprise | Beat by $1.163M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.53 |
EPS GAAP Estimate | $-0.53 |
Revenue Estimate | $0.0004785B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | -1.98 | -10.12 | -3.24931 | -1.17507 | 5 |
Dec 2028 | -2.95667 | -6.78 | -4.90103 | -1.86062 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.862 | -0.26083 | 0.001163B | 24.85% | 0.92M |
FQ4 2024 (Dec 2024) | 0 | 0.626 | 0.001326B | 65.54% | 0.86M |
FQ3 2024 (Sep 2024) | 0 | 0.518 | 0B | NAN% | -0.47M |
FQ2 2024 (Jun 2024) | -0.51 | -0.51 | 0.001863B | 100% | 1.86M |
FQ1 2024 (Mar 2024) | -0.54 | -0.54 | 0.000874B | 100% | 0.87M |
FQ1 2023 (Mar 2023) | -7.7 | -7.7 | 0B | NAN% | 0M |
FQ4 2023 (Dec 2023) | -0.71 | -0.71 | 0.000457B | 100% | 0.46M |
FQ1 2017 (Mar 2017) | -0.22 | -0.22 | 0B | NAN% | 0M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.53
Consensus Revenue Estimates
0.0004785B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | -0.755 | -- | -0.755 | -0.755 | 1 |
FQ2 2027 (Jun 2027) | -0.7384 | -- | -0.7384 | -0.7384 | 1 |
FQ1 2027 (Mar 2027) | -0.7222 | -- | -0.7222 | -0.7222 | 1 |
FQ3 2026 (Sep 2026) | -0.8307 | -- | -0.8307 | -0.8307 | 1 |
FQ2 2026 (Jun 2026) | -0.80675 | -- | -0.80675 | -0.80675 | 1 |
FQ1 2026 (Mar 2026) | -0.7478 | -15.27 | -0.7478 | -0.7478 | 1 |
FQ4 2025 (Oct 2025) | -0.55 | -- | -0.57979 | -0.52021 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 5 |
FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 4 |
FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 4 |
FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 4 |
FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 5 |
FQ1 2026 (Mar 2026) | 0B | -365.2 | 0B | 0B | 6 |
FQ4 2025 (Oct 2025) | 0B | -177.12 | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
1
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.60117 | -0.862 | -0.26083 | 30.26% |
FQ4 2024 (Dec 2024) | -0.626 | 0 | 0.626 | INF% |
FQ3 2024 (Sep 2024) | -0.518 | 0 | 0.518 | INF% |
FQ2 2024 (Jun 2024) | -0.51 | -0.51 | 100% | |
FQ1 2024 (Mar 2024) | -0.54 | -0.54 | 100% | |
FQ1 2023 (Mar 2023) | -7.7 | -7.7 | 100% | |
FQ4 2023 (Dec 2023) | -0.71 | -0.71 | 100% | |
FQ1 2017 (Mar 2017) | -0.22 | -0.22 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0B | $0.92M | 79.43% |
FQ4 2024 (Dec 2024) | $0B | $0B | $0.86M | 64.52% |
FQ3 2024 (Sep 2024) | $0B | $0B | $-0.47M | -INF% |
FQ2 2024 (Jun 2024) | $0B | $0B | $1.86M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0.87M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0.46M | 100% |
FQ1 2017 (Mar 2017) | $0B | $0B | $0M | NAN% |